Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COLY-MYCIN M | Par Pharmaceutical | N-050108 RX | 1982-01-01 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
colistimethate | ANDA | 2022-12-02 |
colistimethate sodium | ANDA | 2023-10-25 |
coly-mycin | New Drug Application | 2018-12-03 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ventilator-associated pneumonia | D053717 | EFO_1001865 | J95.851 | — | 4 | 11 | 2 | 3 | 17 |
Infections | D007239 | EFO_0000544 | — | — | 1 | 5 | 2 | 4 | 11 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | 1 | 3 | 5 | 1 | 11 |
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 2 | 4 | 1 | 4 | 9 |
Healthcare-associated pneumonia | D000077299 | — | — | — | 2 | 3 | 1 | — | 5 |
Bacterial infections | D001424 | — | A49 | 1 | 1 | 2 | 1 | 1 | 5 |
Acinetobacter infections | D000151 | EFO_1000792 | — | — | — | — | 1 | 3 | 4 |
Critical illness | D016638 | — | — | 1 | — | 1 | 1 | — | 3 |
Gram-negative bacterial infections | D016905 | — | — | — | — | — | 3 | — | 3 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | 1 | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | HP_0100806 | A41.9 | 1 | 2 | 3 | — | 3 | 7 |
Pneumonia | D011014 | EFO_0003106 | — | 1 | — | 3 | — | 1 | 5 |
Healthy volunteers/patients | — | — | — | 1 | — | 3 | — | — | 4 |
Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | — | — | 1 | — | 1 | 2 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | 1 | — | 1 | 2 |
Septic shock | D012772 | — | A48.3 | — | — | 1 | — | — | 1 |
Iatrogenic disease | D007049 | — | — | — | — | 1 | — | — | 1 |
Bronchitis | D001991 | — | J40 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pseudomonas aeruginosa | D011550 | NCBITaxon_287 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pseudomonas infections | D011552 | EFO_0001076 | A41.52 | 1 | — | — | — | 1 | 2 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | — | — | — | — | 1 |
Pneumococcal infections | D011008 | EFO_0000772 | J13 | 1 | — | — | — | — | 1 |
Gram-negative bacteria | D006090 | — | — | 1 | — | — | — | — | 1 |
Hepatic encephalopathy | D006501 | — | K72.91 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Klebsiella pneumoniae | D007711 | NCBITaxon_573 | B96.1 | — | — | — | — | 1 | 1 |
Drug common name | Colistimethate |
INN | colistimethate sodium |
Description | Colistin, also known as polymyxin E, is an antibiotic medication used as a last-resort treatment for multidrug-resistant Gram-negative infections including pneumonia. These may involve bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, or Acinetobacter. It comes in two forms: colistimethate sodium can be injected into a vein, injected into a muscle, or inhaled, and colistin sulfate is mainly applied to the skin or taken by mouth. Colistimethate sodium is a prodrug; it is produced by the reaction of colistin with formaldehyde and sodium bisulfite, which leads to the addition of a sulfomethyl group to the primary amines of colistin. Colistimethate sodium is less toxic than colistin when administered parenterally. In aqueous solutions it undergoes hydrolysis to form a complex mixture of partially sulfomethylated derivatives, as well as colistin. Resistance to colistin began to appear as of 2015.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCC(C)CCCCC(=O)N(CS(=O)(=O)O)[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@@H](CN[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)O)NC1=O)[C@@H](C)O |
PDB | — |
CAS-ID | 8068-28-8 |
RxCUI | — |
ChEMBL ID | CHEMBL2304327 |
ChEBI ID | — |
PubChem CID | 5311054 |
DrugBank | DB01111 |
UNII ID | XW0E5YS77G (ChemIDplus, GSRS) |